SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

ANG Lifesciences India trades in green on the BSE

26 Nov 2021 Evaluate

ANG Lifesciences India is currently trading at Rs. 559.60, up by 11.90 points or 2.17% from its previous closing of Rs. 547.70 on the BSE.

The scrip opened at Rs. 547.70 and has touched a high and low of Rs. 575.05 and Rs. 520.35 respectively. So far 84760 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 800.45 on 09-Nov-2021 and a 52 week low of Rs. 35.75 on 01-Jan-2021.

Last one week high and low of the scrip stood at Rs. 575.05 and Rs. 472.05 respectively. The current market cap of the company is Rs. 590.90 crore.

The promoters holding in the company stood at 71.07% and Non-Institutions held 28.93%.

ANG Lifesciences India’s board has decided to invest in the equity shares of ANG Healthcare India. Therefore consequent to the acquisition of 100% Equity stake by the company, ANG Healthcare India will become Wholly-Owned Subsidiary Company of ANG Lifesciences India.

The acquisition will help company in its brand-building, domestic branding and direct marketing initiative for the purposes of staying close to the customer and to serve its vision of providing innovative and high quality products at affordable prices all across the country following ethical business practices. The company’s Board of Directors in their meeting held on November 23, 2021, has decided to the same.

ANG Lifesciences India, incorporated in the year 2006, started with the business of manufacturing and marketing of finished pharmaceutical formulation in a dosage form of Sterile Dry Powder Injection Vial.

ANG Lifesciences Share Price

26.84 0.28 (1.05%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×